IS6441A - 4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar - Google Patents

4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar

Info

Publication number: IS6441A
Authority: IS; Iceland
Prior art keywords: tetrahydroisoquinol; methanesulfonamido; polyunsaturated; dimethoxy; pyridyl
Prior art date: 2000-03-03

Application number

IS6441A

Other languages

English (en)

Inventor

Ann Basford Patricia

Blaise Hodgson Paul

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2002-06-25

Publication date

2002-06-25

2000-03-03 Priority claimed from GB0005200A external-priority patent/GB0005200D0/en

2000-06-28 Priority claimed from GB0015900A external-priority patent/GB0015900D0/en

2002-06-25 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-06-25 Publication of IS6441A publication Critical patent/IS6441A/is

Links

PELLFYXDXSYSSE-UHFFFAOYSA-N n-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-ylquinazolin-2-yl)-3,4-dihydro-1h-isoquinolin-5-yl]methanesulfonamide;methanesulfonic acid Chemical compound CS(O)(=O)=O.COC=1C(OC)=CC2=NC(N3CC4=C(C(=CC=C4)NS(C)(=O)=O)CC3)=NC(N)=C2C=1C1=CC=CC=N1 PELLFYXDXSYSSE-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)

IS6441A 2000-03-03 2002-06-25 4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar IS6441A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0005200A GB0005200D0 (en)	2000-03-03	2000-03-03	New salt form
GB0015900A GB0015900D0 (en)	2000-06-28	2000-06-28	New salt form
PCT/IB2001/000244 WO2001064672A1 (en)	2000-03-03	2001-02-23	4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs

Publications (1)

Publication Number	Publication Date
IS6441A true IS6441A (is)	2002-06-25

Family

ID=26243792

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6441A IS6441A (is)	2000-03-03	2002-06-25	4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar

Country Status (39)

Country	Link
US (1)	US6683085B2 (is)
EP (1)	EP1268468B1 (is)
JP (1)	JP3857919B2 (is)
KR (1)	KR100496089B1 (is)
CN (1)	CN1214029C (is)
AP (1)	AP2002002611A0 (is)
AR (1)	AR029482A1 (is)
AT (1)	ATE253570T1 (is)
AU (1)	AU779118B2 (is)
BG (1)	BG106869A (is)
BR (1)	BR0108910A (is)
CA (1)	CA2398963C (is)
CR (1)	CR6731A (is)
CZ (1)	CZ20022858A3 (is)
DE (1)	DE60101157T2 (is)
DK (1)	DK1268468T3 (is)
EA (1)	EA004748B1 (is)
EE (1)	EE200200496A (is)
ES (1)	ES2208565T3 (is)
GE (1)	GEP20043364B (is)
HN (1)	HN2001000036A (is)
HR (1)	HRP20020718A2 (is)
HU (1)	HUP0300006A3 (is)
IL (1)	IL150634A0 (is)
IS (1)	IS6441A (is)
MA (1)	MA26876A1 (is)
MX (1)	MXPA02008665A (is)
NO (1)	NO20024195L (is)
NZ (1)	NZ519672A (is)
OA (1)	OA12186A (is)
PE (1)	PE20011225A1 (is)
PL (1)	PL365070A1 (is)
PT (1)	PT1268468E (is)
SI (1)	SI1268468T1 (is)
SK (1)	SK12282002A3 (is)
TN (1)	TNSN01034A1 (is)
TR (1)	TR200302130T4 (is)
UA (1)	UA72311C2 (is)
WO (1)	WO2001064672A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0124455D0 (en) *	2001-10-11	2001-12-05	Pfizer Ltd	Pharmaceutical formulations
US7163696B2 (en)	2001-10-11	2007-01-16	Pfizer Inc.	Pharmaceutical formulations
DE10223913A1 (de)	2002-05-29	2003-12-11	Bayer Cropscience Ag	Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) *	2002-09-17	2002-10-23	Pfizer Ltd	Method of treatment
AR043880A1 (es) *	2003-04-22	2005-08-17	Solvay Pharm Gmbh	Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) *	2004-03-16	2005-09-29	Pfizer Limited	Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) *	2008-05-21	2009-11-25	上海艾力斯医药科技有限公司	包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) *	2016-01-29	2016-05-25	中国药科大学	一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4914114A (en)	1984-05-28	1990-04-03	Merck Patent Gesellschaft Mit Breschrankter Haftung	3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
KR950011409B1 (ko) *	1986-09-16	1995-10-04	메르크 파텐트 게젤샤프트 미트 베슈랭크터 하프퉁	히드록시인돌 유도체
GB9700504D0 (en) *	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds

2001
- 2001-02-23 JP JP2001563512A patent/JP3857919B2/ja not_active Expired - Fee Related
- 2001-02-23 KR KR10-2002-7011506A patent/KR100496089B1/ko not_active Expired - Fee Related
- 2001-02-23 CN CNB018052304A patent/CN1214029C/zh not_active Expired - Fee Related
- 2001-02-23 CZ CZ20022858A patent/CZ20022858A3/cs unknown
- 2001-02-23 SK SK1228-2002A patent/SK12282002A3/sk unknown
- 2001-02-23 AU AU35888/01A patent/AU779118B2/en not_active Ceased
- 2001-02-23 NZ NZ519672A patent/NZ519672A/en unknown
- 2001-02-23 EE EEP200200496A patent/EE200200496A/xx unknown
- 2001-02-23 TR TR2003/02130T patent/TR200302130T4/xx unknown
- 2001-02-23 DK DK01908029T patent/DK1268468T3/da active
- 2001-02-23 OA OA1200200266A patent/OA12186A/fr unknown
- 2001-02-23 IL IL15063401A patent/IL150634A0/xx unknown
- 2001-02-23 EA EA200200826A patent/EA004748B1/ru not_active IP Right Cessation
- 2001-02-23 CA CA002398963A patent/CA2398963C/en not_active Expired - Fee Related
- 2001-02-23 HR HR20020718A patent/HRP20020718A2/xx not_active Application Discontinuation
- 2001-02-23 HU HU0300006A patent/HUP0300006A3/hu unknown
- 2001-02-23 BR BR0108910-2A patent/BR0108910A/pt not_active Application Discontinuation
- 2001-02-23 WO PCT/IB2001/000244 patent/WO2001064672A1/en not_active Ceased
- 2001-02-23 MX MXPA02008665A patent/MXPA02008665A/es active IP Right Grant
- 2001-02-23 GE GE4907A patent/GEP20043364B/en unknown
- 2001-02-23 DE DE60101157T patent/DE60101157T2/de not_active Expired - Lifetime
- 2001-02-23 UA UA2002097181A patent/UA72311C2/uk unknown
- 2001-02-23 AT AT01908029T patent/ATE253570T1/de not_active IP Right Cessation
- 2001-02-23 ES ES01908029T patent/ES2208565T3/es not_active Expired - Lifetime
- 2001-02-23 PT PT01908029T patent/PT1268468E/pt unknown
- 2001-02-23 PL PL01365070A patent/PL365070A1/xx unknown
- 2001-02-23 SI SI200130064T patent/SI1268468T1/xx unknown
- 2001-02-23 AP APAP/P/2002/002611A patent/AP2002002611A0/en unknown
- 2001-02-23 EP EP01908029A patent/EP1268468B1/en not_active Expired - Lifetime
- 2001-02-28 HN HN2001000036A patent/HN2001000036A/es unknown
- 2001-02-28 PE PE2001000202A patent/PE20011225A1/es not_active Application Discontinuation
- 2001-03-01 AR ARP010100977A patent/AR029482A1/es unknown
- 2001-03-01 US US09/797,112 patent/US6683085B2/en not_active Expired - Fee Related
- 2001-03-02 TN TNTNSN01034A patent/TNSN01034A1/fr unknown
2002
- 2002-06-24 BG BG106869A patent/BG106869A/bg unknown
- 2002-06-25 IS IS6441A patent/IS6441A/is unknown
- 2002-08-15 MA MA26776A patent/MA26876A1/fr unknown
- 2002-08-19 CR CR6731A patent/CR6731A/es not_active Application Discontinuation
- 2002-09-03 NO NO20024195A patent/NO20024195L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1268468A1 (en)	2003-01-02
JP3857919B2 (ja)	2006-12-13
CA2398963A1 (en)	2001-09-07
BG106869A (bg)	2002-12-29
NO20024195D0 (no)	2002-09-03
AU779118B2 (en)	2005-01-06
ES2208565T3 (es)	2004-06-16
PL365070A1 (en)	2004-12-27
HRP20020718A2 (en)	2004-02-29
EA200200826A1 (ru)	2003-02-27
UA72311C2 (uk)	2005-02-15
WO2001064672A1 (en)	2001-09-07
HUP0300006A2 (en)	2003-05-28
IL150634A0 (en)	2003-02-12
AU3588801A (en)	2001-09-12
CR6731A (es)	2004-03-11
DE60101157D1 (de)	2003-12-11
EE200200496A (et)	2004-02-16
US20020010188A1 (en)	2002-01-24
KR20020080463A (ko)	2002-10-23
MA26876A1 (fr)	2004-12-20
NZ519672A (en)	2004-06-25
PE20011225A1 (es)	2001-12-08
GEP20043364B (en)	2004-03-10
ATE253570T1 (de)	2003-11-15
AR029482A1 (es)	2003-07-02
PT1268468E (pt)	2004-01-30
HUP0300006A3 (en)	2006-01-30
BR0108910A (pt)	2002-12-24
HN2001000036A (es)	2001-07-09
DK1268468T3 (da)	2004-02-09
NO20024195L (no)	2002-09-03
JP2003525289A (ja)	2003-08-26
HK1053655A1 (en)	2003-10-31
SI1268468T1 (en)	2004-04-30
DE60101157T2 (de)	2004-09-02
CN1214029C (zh)	2005-08-10
TR200302130T4 (tr)	2004-01-21
EP1268468B1 (en)	2003-11-05
AP2002002611A0 (en)	2002-09-30
TNSN01034A1 (fr)	2005-11-10
MXPA02008665A (es)	2003-02-24
SK12282002A3 (sk)	2003-10-07
US6683085B2 (en)	2004-01-27
OA12186A (en)	2006-05-09
CA2398963C (en)	2006-10-24
KR100496089B1 (ko)	2005-06-17
EA004748B1 (ru)	2004-08-26
CN1432010A (zh)	2003-07-23
CZ20022858A3 (cs)	2003-09-17

Publication	Publication Date	Title
IS6524A (is)	2002-08-23	5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
MXPA03001928A (es)	2003-06-19	Derivados de quinolina y quinazolina.
ATE309996T1 (de)	2005-12-15	Chinolinonderivate als tyrosin-kinase inhibitoren
NO20012583L (no)	2001-07-19	Kinoliner og kinoksalinforbindelser som PDGF-R- og/eller LCK- tyrosinkinaseinhibitorer
NO20030795D0 (no)	2003-02-20	Kinazolinderivater
NO20021820L (no)	2002-05-23	Tyrosinkinaseinhibitorer
DE60234376D1 (de)	2009-12-24	3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
DE60103974D1 (de)	2004-07-29	Gyrase-inhibitoren und ihre verwendung
EP1161433A4 (en)	2002-05-08	TYROSINE KINASE INHIBITORS
AU2002238042A1 (en)	2002-08-19	Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
NO20005453L (no)	2000-12-20	N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4- quinazolinamin mesylat anhydrat og monohydrat
ATE264328T1 (de)	2004-04-15	Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen
IS6441A (is)	2002-06-25	4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar
NO20035573D0 (no)	2003-12-12	Kinazolinderivater
DE60317675D1 (de)	2008-01-03	KRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-i1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL -1H-INDOL-3-YL -1H-PYRROLE MONO-HYDROCHLORIDE
NO20041520L (no)	2004-04-05	Farmasoytiske formuleringer for kontrollert frigjoring av 4-amino-6,7-dimetoksy-2- (5-metansulfonamido-1,2,3,4-tetrahydroisokinol-2-yl) -5- (2-pyridyl) kinazolin.
DE50107204D1 (de)	2005-09-29	8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
ATE304010T1 (de)	2005-09-15	Piperazinylcarbonylchinoline und isochinoline
NO20025135L (no)	2002-11-27	Antihypertensive midler og anvendelse
EP1453435A4 (en)	2009-02-11	THERMOPOLYMER COMPOSITION AND RELATED METHODS
HK1062439A (en)	2004-11-05	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
AU2002256260A1 (en)	2002-11-05	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ITRM20010478A1 (it)	2003-02-06	Metodo ed apparecchiatura per la perforazione orizzontale.
FI5113U1 (fi)	2001-10-25	Syöksytorvi
ES1045195Y (es)	2001-02-01	Medios de autocentraje y guiado de persianas.